Bringing together real-time monitoring, telemedicine, AI, interventions, and pharmaceuticals into a single device produces a number of potential pitfalls.
Mark Goodman and Barry Thompson, Baker & McKenzie LLP03.04.20
Whether an earthquake or the spread of the coronavirus, recent incidents highlight the reality and complexity associated with managing a global supply chain.
Ryan Oleksy, Co-Founder, Next Life Medical Corporation; Advisor, Sauron Group03.04.20
Expands the firm's pharmaceutical and device research, development, and clinical capabilities that enhance the ability to provide hybrid ophthalmic therapies.